DarioHealth Corp. Payments to Acquire Loans Receivable
DarioHealth Corp. (DRIO) reported Payments to Acquire Loans Receivable of $400.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireLoansReceivable · last filed 2023-03-09
- DarioHealth Corp. payments to acquire loans receivable for fiscal 2021 was $400.00K, a 73.33% decline from fiscal 2020.
- DarioHealth Corp. payments to acquire loans receivable for fiscal 2020 was $1.50M.
- DarioHealth Corp. payments to acquire loans receivable for fiscal 2019 was $0.00.
| Period end | Payments to Acquire Loans Receivable 12 month |
|---|---|
| 2021-12-31 | $400.00K 10-K · filed 2023-03-09 |
| 2020-12-31 | $1.50M 10-K · filed 2022-03-22 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |